1. 李兰娟 中国 浙江大学 中国工程院院士 Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B: A Cross-Sec..
2. 王福生 中国 解放军总医院第五医学中心 中国科学院院士 Efficacy and safety of elbasvir/grazoprevir intreatment-naiveChinese adults with hepatitis C virus i..
3. 王福生 中国 解放军总医院第五医学中心 中国科学院院士 Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin ..
4. 王红阳 中国 海军军医大学 中国工程院院士 Contribution of Hepatitis B Virus Infection to the Aggressiveness of Primary Liver Cancer: A Clinica..
5. 李兰娟 中国 浙江大学 中国工程院院士 Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Resu..
6. Lok, Anna S. 美国 University of Michigan 2022美国医学院院士 Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China
7. 陈建仁 中国 台湾中央研究院 2017美国科学院院士 A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
8. 庄辉 中国 北京大学 中国工程院院士 Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic he..
9. 魏来 中国 清华大学 Sustained virologic response improved the long-term health-related quality of life in patients with ..
10. 魏来 中国 清华大学 Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China
11. 张作风 美国 University of California Los Angeles Comparison of time trends in the incidence of primary liver cancer between China and the United Stat..
12. John,McLauchlan 英国 University of Glasgow The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolution..
13. 魏来 中国 清华大学 Efficacy and safety of elbasvir/grazoprevir intreatment-naiveChinese adults with hepatitis C virus i..
14. 宁琴 中国 华中科技大学 教授、主任医师 Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-a..
15. 宁琴 中国 华中科技大学 教授、主任医师 Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections..
16. 侯金林 中国 南方医科大学 教授 Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections..
17. 魏来 中国 清华大学 Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections..
18. 魏来 中国 清华大学 Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort
19. Erik,De Clercq 比利时 Katholieke Universiteit Leuven(KU Leuven) Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Thera..
20. 魏来 中国 清华大学 Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infec..